Kalgutkar, Amit S.
Pfizer (United States)
2 papers on CoChatORCID 0000-0001-9701-756X
Most cited papers
- Verified
An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
Owen, D. R., Allerton, C. M. N., Anderson, A. S., Aschenbrenner, L., Avery, M., Berritt, S., Boras, B., Cardin, R. D., Carlo, A., Coffman, K. J., et al. (2021) · Science
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 2,033
- Verified
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor
Griffith, D. A., Edmonds, D. J., Fortin, J.-P., Kalgutkar, A. S., Kuzmiski, J. B., Loria, P. M., Saxena, A. R., Bagley, S. W., Buckeridge, C., Curto, J. M., et al. (2022) · Journal of Medicinal Chemistry
Diabetes Treatment and ManagementReceptor Mechanisms and Signaling
Cited by 192
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free